CSIMarket

Erytech Pharma S.a.  (ERYP)
Other Ticker:  
 
 

Erytech Pharma S.a. Growth Comparisons

Select each growth Category to receive further Information



ERYP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) - 27.82% 14.87% 17.17%
Q / Q Revenue Growth (Q4 MRQ) - 12.62% 6.12% 5.96%
Y / Y Revenue Growth (for 12 months ending Q4 TTM) - 33.83% 18.36% %
Seq. Revenue Growth (for 12 months ending Q4 TTM) - 7.53% 5.95% 4.24%
Revenue 5 Year Average Growth - 10.69% 10.39% 12%


ERYP's Growth Comparisons in the IV. Quarter 2021




Erytech Pharma S.a. reported top-line of $ 0 millions in the forth quarter 2021, compare to $ 0 millions in the same quarter a year ago. Revenues in the Biotechnology & Pharmaceuticals industry grew by 27.82%, while the top-line in the Healthcare sector increased by 14.87%, and overall market improved by 17.17% from the forth quarter 2020.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the forth quarter 2021 earnings reports, average yearly sales growth is 12%.


Growth Rates of ERYP's Income in the forth quarter 2021


ERYP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 83.57% 212.19% 83.52%
Seq. Operating Income Change (Q4 MRQ) - 6.45% -4.45% 14.18%
Y / Y Operating Income Growth (Q4 TTM) - 124.33% 85.38% 86.1%
Seq. Operating Income Growth (Q4 TTM) - 19.3% 25.15% 14.46%
Operating Income 5 Year Avg. Change - -0.66% 10.29% 17.25%


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - 418.1% 287.65% 73.49%
Seq. Income from Cont. Ops. Change (Q4 MRQ) - 17.14% -13.63% 5.53%
Y / Y Income from Cont. Ops. Change (Q4 TTM) - 416.45% 159.04% 109.06%
Seq. Income from Cont. Ops. Change (Q4 TTM) - 47.74% 43.82% 12.63%
Income from Cont. Ops. 5 Year Avg. Change - 5.04% 19.96% 20.08%

ERYP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 415.24% 348.95% 77.85%
Q / Q Net Income Growth (Q4 MRQ) - 17.16% -14.37% 4.63%
Y / Y Net Income Change (Q4 TTM) - 394.64% 166.69% 112.83%
Seq. Net Income Change (Q4 TTM) - 46.25% 44.8% 13.13%
Net Income 5 Year Avg. Growth - 4.89% 20.2% 20.28%

ERYP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 1822.97% 287.65% 73.49%
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - -6.43% -13.63% 5.53%
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) - - -0% -99.31%
EPS from Cont. Ops. 5 Year Avg. Growth - NAN% 19.96% 20.08%



ERYP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 1812.38% 348.95% 20.08%
Q / Q EPS Net Growth (Q4 MRQ) - -6.42% -14.37% 4.63%
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 48993.38%
Seq. EPS Net Change (for 12 months ending Q4 TTM) - - - 0.19%
EPS Net 5 Year Avg. Change - 4.89% 20.2% 20.28%
Expected EPS Growth (Y/Y) - - 123.59% 59.3%



Erytech Pharma S.a. reported bottom-line of $ -2.54 in the forth quarter, compare to $ -4.47 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry grew by 1812.38%, while Healthcare sector increased by 348.95%, and overall market improved by 77.85%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the forth quarter 2021 financial results, average yearly income per share growth is 20.28%.

ERYP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 37.69% -5.79% 66.76%
Seq. Free Cash Flow Change (Q4 MRQ) - -22.43% -20.14% 45.98%
Y / Y Free Cash Flow Change (Q4 TTM) - 47.93% 18.34% 44.84%
Seq. Free Cash Flow Change (Q4 TTM) - 7.72% 25.06% 14.27%
Free Cash Flow 5 Year Avg. Change - 8.62% 21.04% 25.18%

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - - -65.65%
Seq. Net Cash Flow Change (Q4 MRQ) - - - 2.88%
Y / Y Net Cash Flow Change (Q4 TTM) - - -14.42% -73.9%
Seq. Net Cash Flow Change (Q4 TTM) - 196.55% 1809.19% -26.6%
Net Cash Flow 5 Year Avg. Change - - 52.92% 123.78%

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -73.84% 3.33% 7.01% 36.16%
Seq. Capital Expenditures Change (Q4 MRQ) - 6.26% 44.26% 75.22%
Y / Y Capital Expenditures Change (Q4 TTM) -73.84% 12.62% 8.81% 19.67%
Seq. Capital Expenditures Change (Q4 TTM) -73.84% 9.64% 16.62% 12.94%
Capital Expenditures 5 Year Avg. Change - 348.15% 160.42% 81.15%

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FRSH's Profile

Stock Price

FRSH's Financials

Business Description

Fundamentals

Charts & Quotes

FRSH's News

Suppliers

FRSH's Competitors

Customers & Markets

Economic Indicators

FRSH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071